- Q1 2024 Nanobiotix SA Earnings Call TranscriptMay 22, 2024€5.41 (-13.93%)Earnings
- Nanobiotix SA 65th ASTRO Annual Meeting 2023 TranscriptOct 05, 2023
- Half Year 2023 Nanobiotix SA Earnings Call TranscriptSep 27, 2023€8 (+0.38%)Earnings
- Nanobiotix SA at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Nanobiotix SA License Agreement with Janssen Briefing TranscriptJul 10, 2023
- Q4 2022 Nanobiotix SA Earnings Call TranscriptApr 25, 2023€2.5 (-27.26%)Earnings
- Nanobiotix SA at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Nanobiotix SA at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Nanobiotix SA Earnings Call TranscriptNov 10, 2022€3.68 (-1.87%)Earnings
- Q2 2022 Nanobiotix SA Earnings Call TranscriptSep 29, 2022€3.5 (-0.43%)Earnings
- Nanobiotix SA at UBS Global Healthcare Conference TranscriptMay 23, 2022
- Q1 2022 Nanobiotix SA Earnings Call TranscriptMay 19, 2022€5.18 (+0.58%)Earnings
- Q4 2021 Nanobiotix SA Earnings Call TranscriptMar 31, 2022Earnings
Nanobiotix SA at Jefferies London Healthcare Conference Transcript
Good afternoon. My name is Peter Welford; I'm one of the European pharma and biotech analysts at Jefferies in London. It's my great pleasure to introduce the next company in this track, which is Nanobiotix. And here to walk -- brief presentation and then we'll do some Q&A. And from Nanobiotix today, we have the CEO, Laurent Levy, who's going to talk you through his few slides; and then we also have the CFO with me at the front here, Bart Van Rhijn. And I think it was right, you think?
And so we will start off, as I said, over to you, Laurent, with that. And then we'll kick off with some Q&A. (Conference Instructions) We'd love to get some questions.
And with that, over to you. Thank you very much.
Thank you, Peter, and thank you, everyone, for being here. Happy to have this new conference in presence. That's always nice. Today, we're going to talk about Nanobiotix and make -- focus on our primary plan, which is to build a franchise in head and neck with our lead
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)